Loading...
Harrow Health, Inc. 11.875% Senior Notes due 2027
HROWM•NASDAQ
HealthcareMedical - Pharmaceuticals
$25.98
$-0.06(-0.21%)
Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM) Company Profile & Overview
Explore Harrow Health, Inc. 11.875% Senior Notes due 2027’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM) Company Profile & Overview
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
SectorHealthcare
IndustryMedical - Pharmaceuticals
CEOMark L. Baum
Contact Information
Nashville
Company Facts
217 Employees
IPO DateDec 29, 2022
CountryUS
Actively Trading